
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded suppository containing pseudoephedrine hydrochloride, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
FDA-approved products containing pseudoephedrine are listed in tablet, syrup, capsule and solution forms. No finished pseudoephedrine product of any kind is listed in suppository form.
Suppository bases differ, and the base used decides how USP <795> classifies the preparation for beyond-use dating. The date printed on the label is the one to follow.
Compounded drugs are not FDA-approved. This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.
Pseudoephedrine is a nasal decongestant (a sympathomimetic) taken by mouth that a pharmacy may compound when a prescriber orders it.
Pseudoephedrine is a sympathomimetic decongestant. It acts largely by releasing the body's own norepinephrine, which narrows the swollen blood vessels in the nose and sinuses. Pseudoephedrine hydrochloride is sold without a prescription in Drug Facts products such as Sudafed Sinus Congestion tablets, marketed under the OTC monograph, and Sudafed Sinus Congestion 12 Hour tablets, marketed over the counter under an ANDA. Their labeled use is temporary relief of nasal and sinus congestion from the common cold, hay fever or other upper respiratory allergies. It also appears in prescription combination products, such as brompheniramine, pseudoephedrine and dextromethorphan syrup, indicated for coughs and upper respiratory symptoms of allergy or the common cold. A prescriber might order pseudoephedrine compounded in a form or combination that is not manufactured. Compounded preparations are not FDA-approved and require a prescription.
Pseudoephedrine products have no boxed warning. The Drug Facts label says not to use it while taking a monoamine oxidase inhibitor (MAOI) or for 2 weeks after stopping one, and to ask a doctor first if you have heart disease, high blood pressure, thyroid disease, diabetes or trouble urinating from an enlarged prostate. MedlinePlus adds glaucoma, warns that large amounts of caffeine can worsen side effects, and cautions against taking several cold products with the same ingredient. A prescription combination label notes it may reduce the effect of blood pressure medicines. Stop and ask for advice if nervousness, dizziness or sleeplessness occur, or if symptoms do not improve within 7 days or occur with a fever. If you are pregnant, ask before use. LactMed notes that small amounts reach breast milk and that it can reduce milk supply. Talk to your prescriber or pharmacist about side effects.
Pseudoephedrine is a sympathomimetic with indirect alpha-adrenergic activity, through release of endogenous norepinephrine, and direct beta-adrenergic activity, per a 2021 review; decongestion results from vasoconstriction of dilated nasal arterioles. It is well absorbed orally, with onset in about 30 minutes and peak levels at 1 to 4 hours (2 to 6 hours for extended-release forms). Half-life ranges from 3 to 16 hours and depends on urinary pH: acidic urine shortens it and alkaline urine lengthens it. Most of a dose (43 to 96%) is excreted unchanged in urine. Labeled use of the OTC products is temporary relief of nasal and sinus congestion. The prescription brompheniramine, pseudoephedrine and dextromethorphan syrup (ANDA) is contraindicated in newborns, premature infants, nursing mothers, and severe hypertension or severe coronary artery disease. Avoid MAOIs; the review cites a 14-day interval. Case reports describe hypertensive crisis, myocardial infarction and stroke, mostly with risk factors. LactMed advises against use in mothers whose lactation is not well established or who have low milk supply. Dosing is per prescriber. DEA identifies pseudoephedrine as a List I chemical; under the Combat Methamphetamine Epidemic Act, nonprescription retail sales require behind-the-counter placement, photo ID, a logbook and daily and 30-day purchase limits.
Wash your hands. If the suppository is soft, chill it in its wrapper in the refrigerator or under cool water for a few minutes, then unwrap it. For rectal use, coat the tip with a water-soluble lubricant (not petroleum jelly), lie on your side with your upper knee bent, and insert it pointed end first past the muscle at the opening. For vaginal use, lie on your back with knees bent and insert it as far as it comfortably goes, by finger or applicator; bedtime use limits leakage, and a panty liner protects clothing. Stay lying down about 15 minutes. Wash your hands.
Suppositories are nonaqueous, so under USP <795> they can carry a beyond-use date of up to 180 days at controlled room temperature or in the refrigerator when no other stability data apply. Storage depends on the base: fatty bases can soften at room temperature and may be labeled for the refrigerator, while polyethylene glycol bases usually do not need refrigeration. Keep them cool so they do not melt, and refrigerate them if your label says to.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Insert 1 unwrapped suppository